These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 23314304)

  • 41. Detection and Characterization of Circulating Tumor Associated Cells in Metastatic Breast Cancer.
    Mu Z; Benali-Furet N; Uzan G; Znaty A; Ye Z; Paolillo C; Wang C; Austin L; Rossi G; Fortina P; Yang H; Cristofanilli M
    Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27706044
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phenotypes of circulating tumour cells predict time to castration resistance in metastatic castration-sensitive prostate cancer.
    Yang YJ; Kong YY; Li GX; Wang Y; Ye DW; Dai B
    BJU Int; 2019 Aug; 124(2):258-267. PubMed ID: 30536520
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Circulating tumor cells: liquid biopsy].
    Alix-Panabières C; Pierga JY
    Bull Cancer; 2014 Jan; 101(1):17-23. PubMed ID: 24445939
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mesenchymal marker and LGR5 expression levels in circulating tumor cells correlate with colorectal cancer prognosis.
    Wang W; Wan L; Wu S; Yang J; Zhou Y; Liu F; Wu Z; Cheng Y
    Cell Oncol (Dordr); 2018 Oct; 41(5):495-504. PubMed ID: 29949050
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Circulating tumor cells in breast cancer--current status and perspectives.
    Banys-Paluchowski M; Krawczyk N; Meier-Stiegen F; Fehm T
    Crit Rev Oncol Hematol; 2016 Jan; 97():22-9. PubMed ID: 26563820
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Circulating tumor cells (CTCs) as a liquid biopsy material and drug target.
    Cai LL; Ye HM; Zheng LM; Ruan RS; Tzeng CM
    Curr Drug Targets; 2014; 15(10):965-72. PubMed ID: 25182470
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epithelial-mesenchymal plasticity in circulating tumor cells.
    Alix-Panabières C; Mader S; Pantel K
    J Mol Med (Berl); 2017 Feb; 95(2):133-142. PubMed ID: 28013389
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Circulating tumor cell enumeration with a combination of epithelial cell adhesion molecule- and cell-surface vimentin-based methods for monitoring breast cancer therapeutic response.
    Satelli A; Brownlee Z; Mitra A; Meng QH; Li S
    Clin Chem; 2015 Jan; 61(1):259-66. PubMed ID: 25336717
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Detection of circulating tumor cells from peripheral blood in prostate cancer].
    Thalgott M; Heck MM; Pantel K
    Urologe A; 2014 Apr; 53(4):509-13. PubMed ID: 24671249
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Circulating tumor cells as promising novel biomarkers in solid cancers.
    Lianidou ES; Strati A; Markou A
    Crit Rev Clin Lab Sci; 2014 Jun; 51(3):160-71. PubMed ID: 24641350
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical indications for, and the future of, circulating tumor cells.
    Moon DH; Lindsay DP; Hong S; Wang AZ
    Adv Drug Deliv Rev; 2018 Feb; 125():143-150. PubMed ID: 29626548
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Opportunities and Challenges for Pancreatic Circulating Tumor Cells.
    Nagrath S; Jack RM; Sahai V; Simeone DM
    Gastroenterology; 2016 Sep; 151(3):412-26. PubMed ID: 27339829
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic values of cancer associated macrophage-like cells (CAML) enumeration in metastatic breast cancer.
    Mu Z; Wang C; Ye Z; Rossi G; Sun C; Li L; Zhu Z; Yang H; Cristofanilli M
    Breast Cancer Res Treat; 2017 Oct; 165(3):733-741. PubMed ID: 28687903
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Functional Studies on Viable Circulating Tumor Cells.
    Pantel K; Alix-Panabières C
    Clin Chem; 2016 Feb; 62(2):328-34. PubMed ID: 26637479
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Circulating tumor cells in breast cancer: detection systems, molecular characterization, and future challenges.
    Lianidou ES; Markou A
    Clin Chem; 2011 Sep; 57(9):1242-55. PubMed ID: 21784769
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic and therapeutic significance of circulating tumor cells in patients with lung cancer.
    Yousefi M; Ghaffari P; Nosrati R; Dehghani S; Salmaninejad A; Abarghan YJ; Ghaffari SH
    Cell Oncol (Dordr); 2020 Feb; 43(1):31-49. PubMed ID: 31828552
    [TBL] [Abstract][Full Text] [Related]  

  • 57. What's new on circulating tumor cells? A meeting report.
    Lianidou ES; Mavroudis D; Sotiropoulou G; Agelaki S; Pantel K
    Breast Cancer Res; 2010; 12(4):307. PubMed ID: 20727231
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Significance of Circulating Tumour Cells in the Clinic.
    Abalde-Cela S; Piairo P; Diéguez L
    Acta Cytol; 2019; 63(6):466-478. PubMed ID: 30820013
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The biology of circulating tumor cells.
    Pantel K; Speicher MR
    Oncogene; 2016 Mar; 35(10):1216-24. PubMed ID: 26050619
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Targeting circulating tumor cells to prevent metastases.
    Gostomczyk K; Marsool MDM; Tayyab H; Pandey A; Borowczak J; Macome F; Chacon J; Dave T; Maniewski M; Szylberg Ł
    Hum Cell; 2024 Jan; 37(1):101-120. PubMed ID: 37874534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.